全文获取类型
收费全文 | 1819828篇 |
免费 | 124617篇 |
国内免费 | 3822篇 |
专业分类
耳鼻咽喉 | 25765篇 |
儿科学 | 59740篇 |
妇产科学 | 51653篇 |
基础医学 | 265434篇 |
口腔科学 | 51885篇 |
临床医学 | 156896篇 |
内科学 | 358303篇 |
皮肤病学 | 44347篇 |
神经病学 | 139805篇 |
特种医学 | 69122篇 |
外国民族医学 | 242篇 |
外科学 | 275862篇 |
综合类 | 39347篇 |
现状与发展 | 4篇 |
一般理论 | 535篇 |
预防医学 | 128349篇 |
眼科学 | 45281篇 |
药学 | 127859篇 |
7篇 | |
中国医学 | 4520篇 |
肿瘤学 | 103311篇 |
出版年
2019年 | 13551篇 |
2018年 | 20113篇 |
2017年 | 15370篇 |
2016年 | 16830篇 |
2015年 | 21655篇 |
2014年 | 29420篇 |
2013年 | 42256篇 |
2012年 | 55808篇 |
2011年 | 58355篇 |
2010年 | 36074篇 |
2009年 | 34053篇 |
2008年 | 54802篇 |
2007年 | 57950篇 |
2006年 | 58746篇 |
2005年 | 55606篇 |
2004年 | 53580篇 |
2003年 | 49661篇 |
2002年 | 46774篇 |
2001年 | 92426篇 |
2000年 | 94244篇 |
1999年 | 77739篇 |
1998年 | 20720篇 |
1997年 | 18248篇 |
1996年 | 18713篇 |
1995年 | 18213篇 |
1994年 | 16800篇 |
1993年 | 15527篇 |
1992年 | 58874篇 |
1991年 | 56554篇 |
1990年 | 54127篇 |
1989年 | 51765篇 |
1988年 | 47087篇 |
1987年 | 45944篇 |
1986年 | 43171篇 |
1985年 | 40810篇 |
1984年 | 30251篇 |
1983年 | 25629篇 |
1982年 | 14826篇 |
1981年 | 13267篇 |
1979年 | 26398篇 |
1978年 | 18584篇 |
1977年 | 15682篇 |
1976年 | 14527篇 |
1975年 | 15333篇 |
1974年 | 18410篇 |
1973年 | 17786篇 |
1972年 | 16346篇 |
1971年 | 15060篇 |
1970年 | 14007篇 |
1969年 | 13254篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
H Gunen S S Hacievliyagil O Yetkin G Gulbas L C Mutlu E In 《The European respiratory journal》2007,29(4):660-667
The present study was designed to evaluate the hypothesis that nebulised budesonide (NB) might be an alternative to systemic corticosteroids (SC) in the treatment of patients with exacerbations of chronic obstructive pulmonary disease (ECOPD). Patients hospitalised with ECOPD (n = 159) were randomised into three groups. Group 1 received only standard bronchodilator treatment (SBDT), group 2 received SC (40 mg prednisolone) plus SBDT, and group 3 received NB (1,500 microg q.i.d.) plus SBDT. Improvement during 10-day hospitalisation was compared with exacerbation and rehospitalisation rates after discharge. While mean+/-sd age was 64.1+/-8.9 yrs (female/male = 0.1), mean forced expiratory volume in one second (FEV(1)) at admission was found to be 37.2+/-12.2% predicted. Arterial blood gases and spirograms recovered faster in groups 2 and 3. While improvements in arterial oxygen tension (P(a,O(2))) and forced vital capacity (FVC) in group 2, and improvements in P(a,O(2)), FVC and FEV(1) in group 3, became significant at 24-h control, the first significant improvement in group 1 appeared in arterial oxygen saturation at 72-h control. The mean improvement of P(a,O(2)) after 10 days was 1.20 and 1.06 kPa (9 and 8 mmHg) higher in group 2 and 3, respectively, than in group 1. Blood glucose exhibited an upward trend only in group 2. The study demonstrates that nebulised budesonide may be an effective and safe alternative to systemic corticosteroids in the treatment of exacerbations of chronic obstructive pulmonary disease. 相似文献
992.
A. Fuerst S. Derungs B.
Von Rechenberg J. A. Auer J. Schense J. Watson 《Transboundary and Emerging Diseases》2007,54(2):107-112
To describe the treatment of a subchondral bone cyst in the proximal phalanx with parathyroid hormone peptide‐enriched fibrin hydrogel in a warmblood filly. The cyst was localized with computer‐assisted orthopaedic surgery, then curetted and finally filled with parathyroid hormone fragment peptide 1–34 (PTH1−34) covalently attached to a fibrin hydrogel. The cyst healed quickly without any complications. This result supports the hypothesis that PTH1−34 delivered locally in a fibrin hydrogel may improve the postoperative prognosis of surgical management of subchondral bone cysts in horses. Subchondral bone cysts are fairly common in horses. Especially in older horses, the prognosis is poor, even after surgical curettage. Therefore, different management protocols have been investigated in conjunction with surgical curettage to improve prognosis. Locally delivered PTH1−34 seems to be a new method in the treatment of subchondral bone cysts. 相似文献
993.
S R Coughlin L Mawdsley J A Mugarza J P H Wilding P M A Calverley 《The European respiratory journal》2007,29(4):720-727
Obstructive sleep apnoea is associated with increased blood pressure and other features of the metabolic syndrome. The aim of the present study was to determine the relative effectiveness of continuous positive airway pressure (CPAP) in modifying these outcomes. A randomised placebo-controlled blinded crossover trial comparing cardiovascular and metabolic outcomes after 6 weeks of therapeutic and sham CPAP was performed in 34 CPAP-na?ve patients (mean+/-SD body mass and respiratory disturbance indices were 36.1+/-7.6 and 39.7+/-13.8, respectively). Mean waking systolic and diastolic blood pressure fell by 6.7 and 4.9 mmHg, respectively, when compared with sham CPAP. No change was observed in glucose, lipids, insulin resistance or the proportion of patients with metabolic syndrome. In CPAP-compliant patients the fall in blood pressure was greater and the baroreceptor sensitivity improved significantly but no metabolic variable changed. In obese Caucasians with untreated obstructive sleep apnoea, continuous positive airways pressure can improve baroreceptor responsiveness and reduce waking blood pressure within 6 weeks, but this treatment period was insufficient to modify insulin resistance or change the metabolic profile. The mechanisms underlying this difference in the time course of blood pressure and metabolic response to continuous positive airway pressure in obstructive sleep apnoea requires further exploration. 相似文献
994.
A Nonell S Kerk F Lederbogen D Kopf B Hamann S Lewicka M Deuschle 《Experimental and clinical endocrinology & diabetes》2004,112(1):59-61
Preclinical research suggests adrenal beta-adrenergic receptors to be involved in the regulation of steroid synthesis. In a group of healthy male volunteers, we compared ACTH-induced cortisol and dehydroepiandrosterone (DHEA) secretion after pre-treatment with orciprenaline, propranolol or placebo. Neither baseline nor ACTH-induced steroid secretion differed between these conditions. Our data do not support the hypothesis that the adrenal beta-receptor plays a major role in steroid secretion in humans. 相似文献
995.
996.
997.
Céline Chipoy Martine Berreur Séverine Couillaud Gilbert Pradal Fran?ois Vallette Caroline Colombeix Fran?oise Rédini Dominique Heymann Frédéric Blanchard 《Journal of bone and mineral research》2004,19(11):1850-1861
The effects of OSM on proliferation and differentiation of osteosarcoma and nontransformed osteoblasts were analyzed. OSM downregulates osteoblast markers but induces the glial fibrillary acidic protein by the combined activation of PKCdelta and STAT3, offering new lines of therapeutic investigations. INTRODUCTION: Oncostatin M (OSM) is a multifunctional cytokine of the interleukin-6 family implicated in embryonic development, differentiation, inflammation, and regeneration of various tissues, mainly the liver, bone, and the central nervous and hematopoietic systems. One particularity of OSM relies on its growth inhibitory and pro-differentiating effects on a variety of tumor cell lines such as melanoma, providing arguments for a therapeutic application of OSM. The objective of this study was to analyze the effects of OSM on osteosarcoma cell lines proliferation and differentiation. MATERIALS AND METHODS: Proliferation was analyzed by 3H thymidine incorporation. Differentiation was analyzed by semiquantitative RT-PCR and immunocytochemistry for various markers. Alizarin red S staining was used to evaluate bone nodule formation. Morphological changes were studied by confocal and electron microscopy. Western blotting, kinases inhibitors, and dominant negative STAT3 were used to identified the signaling pathways implicated. RESULTS: OSM inhibits the growth of rat osteosarcoma cell lines as well as normal osteoblasts, in correlation with induction of the cyclin-dependent kinases inhibitor p21WAF1. However, OSM reduces osteoblast markers such as alkaline phosphatase, osteocalcin, and bone sialoprotein, leading to strong inhibition of mineralized nodule formation. This inhibitory effect is restricted to mature osteoblasts and differentiated osteosarcoma because OSM effectively stimulates osteoblast markers and bone nodule formation in early, but not late, bone marrow mesenchymal stem cell (BMSC) cultures. In osteosarcoma cells or BMSC, OSM induces expression of the glial fibrillary acidic protein (GFAP) as well as morphological and ultrastructural changes, for example, elongated shape and bundles of microfilaments in cell processes. Rottlerin (PKCdelta inhibitor), and to a lesser degree UO126 (MEK/ERK inhibitor), prevents the loss of osteoblastic markers by OSM, whereas dominant negative STAT3 prevents GFAP induction. CONCLUSIONS: These results highlight the particular gene expression profile of OSM-treated osteosarcoma cells and BMSCs, suggesting either a osteocytic or a glial-like phenotype. Together with the implication of PKCdelta, ERK1/2, and STAT3, these results offer new lines of investigations for neural cell transplantation and osteosarcoma therapy. 相似文献
998.
999.
1000.
K. Bahlke T. Scholbach T. Rhein F. Deckert A. Tannapfel J. Hauss Prof. Dr. H. Witzigmann 《Gef?sschirurgie》2004,9(3):215-219
The celiac axis compression syndrome is a rare disease in adults. In childhood it is extremely uncommon. Vascular reasons or chronic irritation of the celiac ganglion are discussed as causes for this syndrome, leading to chronic abdominal pain. Lateral aortography is acknowledged to be the best method for diagnosis of the celiac axis compression syndrome. New duplex scanning methods are gaining more and more importance. The indication for surgery is the subject of controversy in the current literature. We present the case of a 15-year-old girl who recovered completely after transsection of the ligamentum arcuatum medianum and resection of the celiac ganglion. 相似文献